Canakinumab improves patient-reported outcomes in children and adults with autoinflammatory recurrent fever syndromes: results from the CLUSTER trial
Publication year
2021Source
Clinical and Experimental Rheumatology, 39, 5, (2021), pp. S51-S58ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Internal Medicine
Journal title
Clinical and Experimental Rheumatology
Volume
vol. 39
Issue
iss. 5
Page start
p. S51
Page end
p. S58
Subject
Radboudumc 5: Inflammatory diseases RIMLS: Radboud Institute for Molecular Life Sciences; Internal Medicine - Radboud University Medical Center; Radboud University Medical CenterThis item appears in the following Collection(s)
- Academic publications [246764]
- Faculty of Medical Sciences [93461]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.